CAL-263
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAL-263, covering 2011-05-05 to 2011-05-05. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber [Phase 1]